FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1984367839> ?p ?o ?g. }

• W1984367839 endingPage "55" @default.
• W1984367839 startingPage "33" @default.
• W1984367839 abstract "(1) In all examined rat and human tissues and cells, PIP kinase activity was rate-limiting and PLC activity was present in great excess. (2) The steady-state activities of the signal transduction enzymes, PI kinase, PIP kinase and PLC, and the concentration of the end product, IP3, were determined in rat liver and hepatomas of different malignancies. The activities of all three enzymes were elevated in the hepatomas in a non-random fashion. A generalization emerged that the enzyme with the lowest activity in liver, PIP kinase, increased to the highest extent and the enzyme with the highest activity in liver, PLC, increased to the smallest extent in rapidly growing hepatomas. The IP3 concentration in the hepatomas was elevated in a progression-linked fashion. (3) The three signal transduction enzyme activities were elevated in human ovarian carcinoma samples and in human breast carcinoma cells. (4) When human breast carcinoma MDA-MB-435 cells were allowed to go through lag, log and plateau phases, the IP3 concentration reached a 20-fold peak at 12 hr after plating. The elevation in IP3 concentration preceded the rise in PI and PIP kinase activities which increased 11-fold in the log phase. The IP3 concentration and PI and PIP kinase activities returned to their baseline levels when the plateau phase was reached. The PLC activity did not change significantly during the whole period. (5) Administration of cycloheximide i.p. in rats revealed short half-lives in the bone marrow for the two kinases (8 min) and a long half-life for PLC (> 6 hr). In a group of 10 enzymes, the half-lives of the kinases were the shortest. In cycloheximide-injected rats, the bone marrow IP3 concentration was reduced to about 50% in 30 min. The reduction of IP3 concentration is attributed to the decline to 15 and 12%, respectively, in PI and PIP kinase activities since PLC activity did not change. (6) In 3-day starved rats, the bone marrow PI and PIP kinase were reduced to activities (13%) that were markedly lower than the decrease in the protein concentration (to 55%). By contrast, the PLC activity was preferentially maintained (to 78%) over the protein level. Under starvation, the IP3 concentration decreased (to 24%), indicating that starvation can markedly disrupt IP3 homeostasis. Refeeding returned the enzymic activities and the IP3 concentration to the normal level in bone marrow in 24 hr. (7) Comparison of the absolute activities of PI and PIP kinases and PLC showed that PLC is present in an excess; therefore, it does not appear to have a rate-limiting action in cycloheximide treated rats or in starvation. (8) Whereas PI and PIP kinases have short half-lives and apparently rapid synthetic rates, PLC has high activity, a long half-life and responds to starvation with only a small decrease. (9) The gain in function manifested in the over-expressed capacity for signal transduction confers growth advantages to cancer cells. These increased activities, particularly those of PI and PIP kinases, should be sensitive targets for chemotherapy." @default.
• W1984367839 created "2016-06-24" @default.
• W1984367839 creator A5003177026 @default.
• W1984367839 creator A5006542410 @default.
• W1984367839 creator A5047822251 @default.
• W1984367839 creator A5074850823 @default.
• W1984367839 creator A5079711212 @default.
• W1984367839 creator A5080576843 @default.
• W1984367839 creator A5081913506 @default.
• W1984367839 creator A5084919650 @default.
• W1984367839 date "1996-01-01" @default.
• W1984367839 modified "2023-10-06" @default.
• W1984367839 title "Current issues in the regulation of signal transduction" @default.
• W1984367839 cites W1607412327 @default.
• W1984367839 cites W1775749144 @default.
• W1984367839 cites W1864895841 @default.
• W1984367839 cites W1993636985 @default.
• W1984367839 cites W1997910286 @default.
• W1984367839 cites W1997927440 @default.
• W1984367839 cites W2012723466 @default.
• W1984367839 cites W2018949657 @default.
• W1984367839 cites W2019134311 @default.
• W1984367839 cites W2021664757 @default.
• W1984367839 cites W2027412912 @default.
• W1984367839 cites W2034265850 @default.
• W1984367839 cites W2042414721 @default.
• W1984367839 cites W2062828747 @default.
• W1984367839 cites W2078512742 @default.
• W1984367839 cites W2081330846 @default.
• W1984367839 cites W245727729 @default.
• W1984367839 cites W2475510032 @default.
• W1984367839 doi "https://doi.org/10.1016/0065-2571(96)00003-9" @default.
• W1984367839 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8869739" @default.
• W1984367839 hasPublicationYear "1996" @default.
• W1984367839 type Work @default.
• W1984367839 sameAs 1984367839 @default.
• W1984367839 citedByCount "14" @default.
• W1984367839 countsByYear W19843678392015 @default.
• W1984367839 countsByYear W19843678392017 @default.
• W1984367839 crossrefType "journal-article" @default.
• W1984367839 hasAuthorship W1984367839A5003177026 @default.
• W1984367839 hasAuthorship W1984367839A5006542410 @default.
• W1984367839 hasAuthorship W1984367839A5047822251 @default.
• W1984367839 hasAuthorship W1984367839A5074850823 @default.
• W1984367839 hasAuthorship W1984367839A5079711212 @default.
• W1984367839 hasAuthorship W1984367839A5080576843 @default.
• W1984367839 hasAuthorship W1984367839A5081913506 @default.
• W1984367839 hasAuthorship W1984367839A5084919650 @default.
• W1984367839 hasConcept C126322002 @default.
• W1984367839 hasConcept C134018914 @default.
• W1984367839 hasConcept C181199279 @default.
• W1984367839 hasConcept C184235292 @default.
• W1984367839 hasConcept C185592680 @default.
• W1984367839 hasConcept C195794163 @default.
• W1984367839 hasConcept C28212737 @default.
• W1984367839 hasConcept C55493867 @default.
• W1984367839 hasConcept C62478195 @default.
• W1984367839 hasConcept C71924100 @default.
• W1984367839 hasConcept C86803240 @default.
• W1984367839 hasConceptScore W1984367839C126322002 @default.
• W1984367839 hasConceptScore W1984367839C134018914 @default.
• W1984367839 hasConceptScore W1984367839C181199279 @default.
• W1984367839 hasConceptScore W1984367839C184235292 @default.
• W1984367839 hasConceptScore W1984367839C185592680 @default.
• W1984367839 hasConceptScore W1984367839C195794163 @default.
• W1984367839 hasConceptScore W1984367839C28212737 @default.
• W1984367839 hasConceptScore W1984367839C55493867 @default.
• W1984367839 hasConceptScore W1984367839C62478195 @default.
• W1984367839 hasConceptScore W1984367839C71924100 @default.
• W1984367839 hasConceptScore W1984367839C86803240 @default.
• W1984367839 hasLocation W19843678391 @default.
• W1984367839 hasLocation W19843678392 @default.
• W1984367839 hasOpenAccess W1984367839 @default.
• W1984367839 hasPrimaryLocation W19843678391 @default.
• W1984367839 hasRelatedWork W2011584433 @default.
• W1984367839 hasRelatedWork W2025162880 @default.
• W1984367839 hasRelatedWork W2031737195 @default.
• W1984367839 hasRelatedWork W2040646620 @default.
• W1984367839 hasRelatedWork W2089825149 @default.
• W1984367839 hasRelatedWork W2102581783 @default.
• W1984367839 hasRelatedWork W2112223211 @default.
• W1984367839 hasRelatedWork W2123057090 @default.
• W1984367839 hasRelatedWork W2125379501 @default.
• W1984367839 hasRelatedWork W2115043599 @default.
• W1984367839 hasVolume "36" @default.
• W1984367839 isParatext "false" @default.
• W1984367839 isRetracted "false" @default.
• W1984367839 magId "1984367839" @default.
• W1984367839 workType "article" @default.